Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhiru Zou"'
Publikováno v:
Materials & Design, Vol 238, Iss , Pp 112715- (2024)
Brain glioma is a highly comorbid tumor with high mortality. In this study, plasma complex component-functionalized manganese-doped mesoporous silica nanoparticles (PMMSN) were prepared and loaded with paclitaxel (PTX) by adsorption for brain glioma
Externí odkaz:
https://doaj.org/article/dabfe1d127bf44df8ebeb1feef06639a
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2498-2512 (2022)
Spinal cord injury (SCI) is a serious central nervous system disease, and secondary injury, including oxidative stress, the inflammatory response and accompanying neuronal apoptosis, will aggravate the condition. Due to the existence of the blood–s
Externí odkaz:
https://doaj.org/article/6ef541f3fb61425581ccdd06f5f71c83
Publikováno v:
Materials Today Advances, Vol 15, Iss , Pp 100262- (2022)
Stroke is a central nervous system disease with a high incidence at present. It can cause pathological changes such as oxidative stress, inflammation, neuronal apoptosis, and lead to disturbance of consciousness, disability, and even death. Due to th
Externí odkaz:
https://doaj.org/article/3628e1c6f09c4657a3ea3951029b6509
Publikováno v:
Materials & Design, Vol 219, Iss , Pp 110818- (2022)
The objective of this study was to prepare Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals (HCNCs) as a targeted delivery module for HER2-positive breast cancer. According to transmission electron microscopy (TEM) image
Externí odkaz:
https://doaj.org/article/1353b0ea96ca4789a68aa2d467b2fa6a
Autor:
Jinyu An, Xue Jiang, Zhe Wang, Yingqiao Li, Zhiru Zou, Qian Wu, Le Tong, Xifan Mei, He Tian, Chao Wu
Publikováno v:
International journal of pharmaceutics. 628
After primary injury to the spinal cord, a series of microenvironmental changes can lead to secondary injury. The use of nano-targeted drug delivery systems to improve the postinjury microenvironment, inhibit inflammation and reduce neuronal apoptosi
Publikováno v:
Stem Cell Week; 11/21/2023, p2631-2631, 1p